First-line osimertinib in patients with epidermal growth factor receptor–mutant non–small-cell lung cancer and with a coexisting low allelic fraction of Thr790Met

1. Majem, M.
2. Sullivan, I.
3. Viteri, S.
4. López-Vivanco, G.
5. Cobo, M.
6. Sánchez, J.M.
7. García-González, J.
8. Garde, J.
9. Sampayo, M.
10. Martrat, G.
11. Malfettone, A.
12. Karachaliou, N.
13. Molina-Vila, M.A.
14. Rosell, R.